1. Home
  2. NEO vs XHR Comparison

NEO vs XHR Comparison

Compare NEO & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • XHR
  • Stock Information
  • Founded
  • NEO 2001
  • XHR 2007
  • Country
  • NEO United States
  • XHR United States
  • Employees
  • NEO N/A
  • XHR N/A
  • Industry
  • NEO Precision Instruments
  • XHR Real Estate Investment Trusts
  • Sector
  • NEO Health Care
  • XHR Real Estate
  • Exchange
  • NEO Nasdaq
  • XHR Nasdaq
  • Market Cap
  • NEO 1.2B
  • XHR 1.3B
  • IPO Year
  • NEO 1999
  • XHR N/A
  • Fundamental
  • Price
  • NEO $10.60
  • XHR $13.48
  • Analyst Decision
  • NEO Buy
  • XHR Buy
  • Analyst Count
  • NEO 10
  • XHR 6
  • Target Price
  • NEO $12.56
  • XHR $13.83
  • AVG Volume (30 Days)
  • NEO 3.0M
  • XHR 1.0M
  • Earning Date
  • NEO 10-28-2025
  • XHR 10-31-2025
  • Dividend Yield
  • NEO N/A
  • XHR 4.11%
  • EPS Growth
  • NEO N/A
  • XHR 139.32
  • EPS
  • NEO N/A
  • XHR 0.55
  • Revenue
  • NEO $709,162,000.00
  • XHR $1,074,772,000.00
  • Revenue This Year
  • NEO $10.74
  • XHR $4.71
  • Revenue Next Year
  • NEO $9.85
  • XHR $2.85
  • P/E Ratio
  • NEO N/A
  • XHR $24.58
  • Revenue Growth
  • NEO 10.10
  • XHR 4.29
  • 52 Week Low
  • NEO $4.72
  • XHR $8.55
  • 52 Week High
  • NEO $19.12
  • XHR $16.50
  • Technical
  • Relative Strength Index (RSI)
  • NEO 59.78
  • XHR 51.33
  • Support Level
  • NEO $9.89
  • XHR $13.44
  • Resistance Level
  • NEO $10.44
  • XHR $14.07
  • Average True Range (ATR)
  • NEO 0.52
  • XHR 0.42
  • MACD
  • NEO -0.03
  • XHR 0.05
  • Stochastic Oscillator
  • NEO 67.92
  • XHR 69.73

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About XHR Xenia Hotels & Resorts Inc.

Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.

Share on Social Networks: